Neurocrine Biosciences, Inc. (NBIX) vs United Therapeutics Corporation (UTHR)
- Neurocrine Biosciences, Inc. NBIX 135.71 −0.91%
- United Therapeutics Corporation UTHR 533.12 −1.55%
Neurocrine Biosciences, Inc. and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. United Therapeutics Corporation is the larger, with a market value of $23.2B against $13.9B — 1.7× the size. United Therapeutics Corporation trades at the lower P/E: 17.6× against 19.2×. Neurocrine Biosciences, Inc. grew revenue faster over the last twelve months: 34.4% against 2.49%. United Therapeutics Corporation has the higher net margin (41.6% vs 20.9%) and the higher return on invested capital (23.4% vs 15.0%). Across the 21 metrics below, United Therapeutics Corporation leads on 11 and Neurocrine Biosciences, Inc. on 10.
Valuation
Profitability
| Metric | NBIX | UTHR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.94% | 86.14% | 53.94% |
| Operating margin | 23.56% | 44.44% | 0.00% |
| Net margin | 20.91% | 41.56% | 0.00% |
| Free cash flow margin | 25.80% | 34.65% | 0.00% |
| Return on equity | 22.09% | 19.32% | (0.40%) |
| Return on assets | 15.26% | 17.33% | (3.32%) |
| Return on invested capital | 15.04% | 23.44% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack